Overview

A Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets in Healthy Participants

Status:
COMPLETED

Trial end date:
2024-05-24

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to determine the relative bioavailability of brensocatib between the pediatric oral solution and oral tablets in healthy participants.

Phase:

PHASE1

Details

Lead Sponsor:

Insmed Incorporated

Treatments:

brensocatib